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Whole genome sequencing of 51 
breast cancers reveals that tumors are devoid 
of bovine leukemia virus DNA
Nicolas A. Gillet1,2*  and Luc Willems1,2*
Abstract 
Controversy exists regarding the association of bovine leukemia virus (BLV) and breast cancer. PCR-based experi-
mental evidence indicates that BLV DNA is present in breast tissue and that as many as 37% of cancer cases may be 
attributable to viral exposure. Since this association might have major consequences for human health, we evalu-
ated 51 whole genomes of breast cancer samples for the presence of BLV DNA. Among 32 billion sequencing reads 
retrieved from the NCBI database of genotype and phenotype, none mapped on different strains of the BLV genome. 
Controls for sequence divergence and proviral loads further validated the approach. This unbiased analysis thus 
excludes a clonal insertion of BLV in breast tumor cells and strongly argues against an association between BLV and 
breast cancer.
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Background
BLV naturally infects cattle, water buffalo, yak and zebu 
[1–4]. Sporadic infections with BLV have occasionally 
been reported in other species like alpaca [5]. Experi-
mentally, BLV can also be transmitted to a number of 
species including sheep [6], goats [6], rats [7] and rabbits 
[8]. BLV infection causes B cell lymphocytosis, leuke-
mia and/or lymphoma in natural and some experimental 
hosts [1]. There is also controversial evidence suggesting 
that BLV might infect humans: (1) antibodies against the 
BLV capsid were detected in 74% of human sera from the 
Berkeley Community, California [9], (2) BLV DNA was 
detected in breast tissues using PCR [10–12]. Based on 
a positive correlation between the rates of BLV infection 
and tumor frequencies (36–59% compared to 29–45% 
in normal tissue), as many as 37% of breast cancer cases 
may be attributable to BLV exposure [12].
Although these observations initiated some skepti-
cism within the scientific community [13], the potential 
consequences for human health clearly require further 
investigation.
Results and discussion
To avoid potential experimental artifacts associated with 
DNA amplification techniques, we directly analyzed 
whole genomes of breast tumors and adjacent tissues. 
After retrieval of raw DNA sequences from the NCBI 
dbGaP [14, 15], paired-reads were probed for alignment 
on different BLV strains using Bowtie2. As a positive 
control, a nuclear DNA fragment (chr12: 53,959,600–
53,964,000) devoid of repeated sequences that would lead 
to an overestimation of aligned reads and set to 4.4 kb to 
fit with the monoploid 8.8 kb BLV genome was selected 
from the human genome. Alignment of 51 breast tumors 
genomes on the nuclear control sequence identified 
between 283 and 1287 paired-reads (illustrated on Fig. 1 
and summarized on Table  1). In contrast, no homology 
was found with 5 different BLV subtypes (highlighted 
in blue on the phylogenic tree of Fig. 2a). In 19 biopsies 
adjacent to the breast tumors, 386–1197 paired-reads 
aligned onto the nuclear DNA sequence whereas none 
mapped on BLV (Table  1). All DNA samples contained 
Open Access
Retrovirology
*Correspondence:  n.gillet@ulg.ac.be; luc.willems@ulg.ac.be 
1 Molecular and Cellular Epigenetics, Interdisciplinary Cluster for Applied 
Genoproteomics (GIGA), University of Liège (ULg), B34, 1 Avenue de 
l’Hôpital, 4000 Sart-Tilman Liège, Belgium
Full list of author information is available at the end of the article
Page 2 of 7Gillet and Willems  Retrovirology  (2016) 13:75 
extranuclear DNA as indicated by alignment of a control 
mitochondrial sequence (NC_012920) (Table 1).
Although no paired-read corresponding to five dif-
ferent BLV variants could be identified, the possibil-
ity remains that extensive sequence variability impaired 
detection. On average, the whole genome sequencing 
procedure generated 660 million reads per sample. Given 
that the BLV provirus length is 8.8 kb and that a normal 
human diploid genome is 6.6 billion base pairs, the aver-
age number of reads that would be generated by a 8.8 kb-
long monoploid sequence is 880 (660,000,000/6600,000,0
00 × 8800). Providing that the BLV provirus is integrated 
in a single copy per cell, the whole genome sequencing 
procedure would thus generate 880 reads on average. If 
the strain in the sample diverges from the five reference 
sequences, a fraction of the reads would not be retrieved. 
Therefore, BLV variants were artificially generated in sil-
ico by introducing 2, 3, 6, 10 and 20% nucleotide changes 
in reference AF033818 (mutants 0.02, 0.03, 0.06, 0.10 and 
0.20, respectively). Phylogenetic analysis of Fig. 2a illus-
trates that in silico generated divergence far exceeds the 
maximal natural sequence variations observed worldwide 
[16]. 880 Illumina-like reads were then simulated from 
these in silico variants using ART simulation tool and 
mapped on BLV genome AF033818. Most reads (818 of 
880) generated from mutant 0.02 aligned on reference 
sequence AF033818 (Fig.  2b). Even the highly divergent 
mutant 0.10 still aligned 41% of its 880 reads on the refer-
ence. Up to 20% divergence in mutant 0.20 was required 
to significantly impair detection, although BLV specific 
reads were still identified (Fig. 2b).
Whole genome analysis thus excludes clonal integra-
tion of natural and highly divergent BLV strains in breast 
tumors. Since only a small proportion of cells may carry 
the provirus, the sensitivity of the analysis was correlated 
to the proviral loads. Any natural BLV variant that would 
infect 10% of the tumor cells is expected to generate 
about 100 reads (Fig.  2c, dotted blue line). The number 
of expected reads decreases along with the percentage of 
infected cells to reach approximately one read with a pro-
viral load of 0.1% (Fig. 2c, dotted blue line). Considering 
a 59% prevalence of breast tumors positive for BLV [12], 
30 samples out of our 51 should be positive. Even with 
an individual proviral load around 0.1%, this should make 
about 30 reads (on average one per patient) mapping on 
BLV, whereas none were found.
Using whole genome analysis, we concluded that there 
is no evidence for a single BLV-specific or even related 
sequence. The discrepancies and limitations of this report 
and others pertain to:
1. The origin of the samples It is indeed possible that 
tumor biopsies from previous studies originating 
from US [11, 12] and Colombia [10] significantly dif-
fer from those reported in the dbGaP NCBI database. 
Even if we restrict our observations on US originat-
ing samples (n = 35), the discrepancy remains highly 
significant. Indeed, Buehring reported 67 breast 
tumors positive for BLV over 114 cases [12] whereas 
we found none over 35 cases (the p value for fisher 
test is 1.12 × 10−6).
2. The DNA extraction technique In situ PCR suggested 
that BLV proviral DNA is localized in the cytoplasm 
[11, 12]. Analysis of mitochondria-specific sequences 
Fig. 1 Representative alignment of dbGaP sequencing reads to 
human and BLV DNA. Breast cancer patients were BRC3 from USA 
(study phs000472), MEX-BR-15 from Mexico and SX1A2 from Vietnam 
(study phs000369). Aligned reads were visualized using integrative 
genomics viewer (IGV)
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(Table 1) shows that dbGaP NCBI database includes 
reads corresponding to 16  kb-long, circular and 
extranuclear mitochondrial DNA.
3. The strain divergence Artificial in silico simulation of 
highly divergent mutants still identified BLV specific 
reads (Fig. 2b). Since nucleotide substitutions among 
BLV strains worldwide are limited to 2.3% [16], it 
remains questionable whether these mutants still 
belong to the same species. Further analysis show 
that breast tumor genomes do not map on HTLV-1 
sequences (data not shown). Why BLV-conserved 
sequences were previously identified by PCR remains 
an enigma.
4. Viral expression Although BLV is expressed at trace 
levels in the bovine species, the p24 viral capsid pro-
tein was detected in 5% of breast tumors [12]. This 
observation is inconsistent with RNASeq analysis of 
154.7 billion of transcriptome sequencing reads from 
The Cancer Genome Atlas Research Network [17, 
18].
Our present study based on whole genome analysis 
excludes a clonal insertion of BLV in tumor cells and does 
not support converging lines of evidence which previ-
ously suggested an association between BLV infection 
and breast cancer.
Methods
Raw DNA sequences from whole genomes of breast 
tumors and normal breast tissues adjacent the tumor 
were retrieved from the NCBI database of genotype and 
phenotype (dbGaP). These sequences were extracted 
from two studies: (1) estrogen receptor positive breast 
cancer: aromatase inhibitor response study (accession 
number phs000472) [14] and (2) sequence analysis of 
mutations and translocations across breast cancer sub-
types (accession number phs000369) [15]. Archive files 
were downloaded with prefetch v2.5.7 and sequencing 
reads were extracted with fastdump v2.5.7 using “split-3” 
option to separate paired reads and single reads (NCBI 
SRA Toolkit). Paired reads were probed for alignment on 
different BLV variants (accession numbers: AF033818, 
AF275515, D00647, K02120, LC080667) and, as posi-
tive control, on human genomic sequences using Bow-
tie2 (version 2.2.5). We used the “very-sensitive” option 
of Bowtie2 to maximize the likelihood of viral detection. 
Fig. 2 Analysis of sequence variation and proviral load in sequence alignments. a Neighbour-joining phylogenetic tree of BLV and HTLV-1 
genomes. b Using the ART simulation tool (NIH), Illumina-like 100 bp paired-reads were generated in silico from the mutants. 880 simulated reads 
were probed for alignment on BLV AF033818 using Bowtie2 and visualized using IGV. c Correlation between proviral loads and predicted number of 
reads
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Analyses were performed on computing cluster running 
on Linux OS. BLV divergent sequences were created in 
silico by introducing substitutions, deletions or insertions 
with equal probabilities in 2, 3, 6, 10 and 20% of the refer-
ence AF033818 (mutants 0.02, 0.03, 0.06, 0.10 and 0.20, 
respectively). Neighbor-joining phylogenetic tree was 
elaborated using Clustal Omega (EMBL-EBI) and visual-
ized by Dendroscope 3. Illumina-like paired-reads were 
generated from the BLV sequence using the ART simu-
lation tool (version GreatSmokyMountains-04-17-2016, 
NIH).
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